These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8877000)

  • 21. Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats.
    McDaid J; Tedford CE; Mackie AR; Dallimore JE; Mickiewicz AL; Shen F; Angle JM; Napier TC
    Drug Alcohol Depend; 2007 Jan; 86(1):55-66. PubMed ID: 16762517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of group III metabotropic glutamate receptors inhibits basal and amphetamine-stimulated dopamine release in rat dorsal striatum: an in vivo microdialysis study.
    Mao L; Lau YS; Wang JQ
    Eur J Pharmacol; 2000 Sep; 404(3):289-97. PubMed ID: 10996594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of adenosine A1- and A2A-receptor agonists on enhancement of dopamine release from the striatum in methamphetamine-sensitized rats.
    Yoshimatsu A; Shimazoe T; Kawashimo A; Shuto T; Doi Y; Fukumoto T; Watanabe S
    Jpn J Pharmacol; 2001 Jun; 86(2):254-7. PubMed ID: 11459131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with methamphetamine plus scopolamine and methamphetamine in rats.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):169-78. PubMed ID: 7941782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vulnerability of synaptic plasticity in the striatum of methamphetamine-sensitized rats.
    Arai I; Shimazoe T; Yoshimatsu A; Inoue H; Shibata S; Watanabe S
    Jpn J Pharmacol; 1998 Sep; 78(1):105-8. PubMed ID: 9804072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo.
    Kazahaya Y; Akimoto K; Otsuki S
    Biol Psychiatry; 1989 Apr; 25(7):903-12. PubMed ID: 2720005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice.
    Miyamoto Y; Ishikawa Y; Iegaki N; Sumi K; Fu K; Sato K; Furukawa-Hibi Y; Muramatsu S; Nabeshima T; Uno K; Nitta A
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1283-94. PubMed ID: 24559655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MK-801 fails to modify the effect of methamphetamine on dopamine release in the rat striatum.
    Kashihara K; Okumura K; Onishi M; Otsuki S
    Neuroreport; 1991 May; 2(5):236-8. PubMed ID: 1912453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats.
    GoĊ‚embiowska K; Konieczny J; Wolfarth S; Ossowska K
    Neuropharmacology; 2003 Sep; 45(4):484-92. PubMed ID: 12907309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of methamphetamine on the release of glutamate from striatal slices.
    Earle ML; Davies JA
    J Neural Transm Gen Sect; 1991; 86(3):217-22. PubMed ID: 1777214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of N-ethylmaleimide on dopamine release in the rat striatum after repeated treatment with methamphetamine.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1994 May; 257(3):243-8. PubMed ID: 7916300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: a positron emission tomography using [18F]fallypride.
    Ota M; Ogawa S; Kato K; Wakabayashi C; Kunugi H
    Psychiatry Res; 2015 Apr; 232(1):92-7. PubMed ID: 25703679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ["Methamphetamine-stereotypies" and brain dopamine levels of rats treated with single or repeated doses of alpha-methyl-para-tyrosine (author's transl)].
    Kobayashi M; Wakamatsu Y; Shinohara M; Teraoka Y; Koshikawa N
    Nihon Yakurigaku Zasshi; 1977 Sep; 73(6):695-701. PubMed ID: 562821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of long-term potentiation of the striatum in methamphetamine-sensitized rats.
    Nishioku T; Shimazoe T; Yamamoto Y; Nakanishi H; Watanabe S
    Neurosci Lett; 1999 Jun; 268(2):81-4. PubMed ID: 10400083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of repeated administration of methamphetamine on dopamine uptake sites in rat striatum.
    Ikawa K; Watanabe A; Motohashi N; Kaneno S
    Neurosci Lett; 1994 Feb; 167(1-2):37-40. PubMed ID: 8177527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid inhibits excess dopamine release in response to a fear-conditioned stimulus in the basolateral complex of the amygdala of methamphetamine-sensitized rats.
    Miyagi J; Oshibuchi H; Kasai A; Inada K; Ishigooka J
    Eur J Pharmacol; 2014 May; 730():20-5. PubMed ID: 24583338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid.
    Eradiri OL; Starr MS
    Eur J Pharmacol; 1999 Dec; 386(2-3):217-26. PubMed ID: 10618473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization.
    Stocco MR; El-Sherbeni AA; Zhao B; Novalen M; Tyndale RF
    Psychopharmacology (Berl); 2021 Jul; 238(7):1791-1804. PubMed ID: 33649968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reduction of preprotachykinin mRNA in the methamphetamine-induced behavioral sensitization.
    Fukamauchi F
    Neuropeptides; 1996 Feb; 30(1):43-6. PubMed ID: 8868298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased striatal glutamate transporter by repeated intermittent administration of methamphetamine.
    Shirai Y; Shirakawa O; Nishino N; Saito N; Nakai H
    Psychiatry Clin Neurosci; 1996 Jun; 50(3):161-4. PubMed ID: 9201764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.